218 related articles for article (PubMed ID: 15645004)
1. New cancer vaccine approaches.
Kaplan JM
Drugs Today (Barc); 2004 Nov; 40(11):913-29. PubMed ID: 15645004
[TBL] [Abstract][Full Text] [Related]
2. Cancer vaccines: finding the best way to train the immune system.
Goldman B
J Natl Cancer Inst; 2002 Oct; 94(20):1523-6. PubMed ID: 12381703
[No Abstract] [Full Text] [Related]
3. [Tumor vaccines-therapeutic vaccination against cancer].
Rammensee HG; Löffler MW; Walz JS; Bokemeyer C; Haen SP; Gouttefangeas C
Internist (Berl); 2020 Jul; 61(7):690-698. PubMed ID: 32462251
[TBL] [Abstract][Full Text] [Related]
4. Cancer vaccination progress.
Pawelec G; Rees RC
Trends Mol Med; 2002 Dec; 8(12):545-6. PubMed ID: 12470983
[TBL] [Abstract][Full Text] [Related]
5. Cellular immunotherapy for cancer: current concepts and clinical perspectives scientific basis and approaches for therapeutic cancer vaccines. Part I.
Quatan N; Spicer J; Plunkett T; Pandha H
Clin Oncol (R Coll Radiol); 2004 Aug; 16(5):356-65. PubMed ID: 15341440
[No Abstract] [Full Text] [Related]
6. Immunological considerations underlying heat shock protein-mediated cancer vaccine strategies.
Kelly M; McNeel D; Fisch P; Malkovsky M
Immunol Lett; 2018 Jan; 193():1-10. PubMed ID: 29129721
[TBL] [Abstract][Full Text] [Related]
7. Therapeutic cancer vaccines: using unique antigens.
Lewis JJ
Proc Natl Acad Sci U S A; 2004 Oct; 101 Suppl 2(Suppl 2):14653-6. PubMed ID: 15297620
[TBL] [Abstract][Full Text] [Related]
8. Heat shock protein--peptide complexes as immunotherapy for human cancer.
Przepiorka D; Srivastava PK
Mol Med Today; 1998 Nov; 4(11):478-84. PubMed ID: 9857367
[TBL] [Abstract][Full Text] [Related]
9. Stress protein/peptide complexes derived from autologous tumor tissue as tumor vaccines.
Heike M; Weinmann A; Bethke K; Galle PR
Biochem Pharmacol; 1999 Nov; 58(9):1381-7. PubMed ID: 10513981
[TBL] [Abstract][Full Text] [Related]
10. Chaperone-rich cell lysates, immune activation and tumor vaccination.
Zeng Y; Graner MW; Katsanis E
Cancer Immunol Immunother; 2006 Mar; 55(3):329-38. PubMed ID: 15887013
[TBL] [Abstract][Full Text] [Related]
11. Heat shock protein-peptide complex in the treatment of glioblastoma.
See AP; Pradilla G; Yang I; Han S; Parsa AT; Lim M
Expert Rev Vaccines; 2011 Jun; 10(6):721-31. PubMed ID: 21692695
[TBL] [Abstract][Full Text] [Related]
12. Heat shock proteins (HSPs) based anti-cancer vaccines.
Ciocca DR; Cayado-Gutierrez N; Maccioni M; Cuello-Carrion FD
Curr Mol Med; 2012 Nov; 12(9):1183-97. PubMed ID: 22804241
[TBL] [Abstract][Full Text] [Related]
13. Cancer vaccines.
Butterfield LH
BMJ; 2015 Apr; 350():h988. PubMed ID: 25904595
[TBL] [Abstract][Full Text] [Related]
14. Anticancer vaccination strategies.
Nencioni A; Grüenbach F; Patrone F; Brossart P
Ann Oncol; 2004; 15 Suppl 4():iv153-60. PubMed ID: 15477300
[No Abstract] [Full Text] [Related]
15. Cancer vaccination.
Del Vecchio M; Parmiani G
Forum (Genova); 1999; 9(3):239-56. PubMed ID: 10504171
[TBL] [Abstract][Full Text] [Related]
16. Progress on new vaccine strategies for the immunotherapy and prevention of cancer.
Berzofsky JA; Terabe M; Oh S; Belyakov IM; Ahlers JD; Janik JE; Morris JC
J Clin Invest; 2004 Jun; 113(11):1515-25. PubMed ID: 15173875
[TBL] [Abstract][Full Text] [Related]
17. Heat-shock protein-based anticancer immunotherapy: an idea whose time has come.
Ménoret A; Chandawarkar R
Semin Oncol; 1998 Dec; 25(6):654-60. PubMed ID: 9865680
[TBL] [Abstract][Full Text] [Related]
18. Heat-shock protein-peptide complex-96 for the treatment of cancer.
Amato RJ
Expert Opin Biol Ther; 2007 Aug; 7(8):1267-73. PubMed ID: 17696824
[TBL] [Abstract][Full Text] [Related]
19. Antigen-specific vaccines for cancer treatment.
Tagliamonte M; Petrizzo A; Tornesello ML; Buonaguro FM; Buonaguro L
Hum Vaccin Immunother; 2014; 10(11):3332-46. PubMed ID: 25483639
[TBL] [Abstract][Full Text] [Related]
20. Vaccination of metastatic melanoma patients with autologous tumor-derived heat shock protein gp96-peptide complexes: clinical and immunologic findings.
Belli F; Testori A; Rivoltini L; Maio M; Andreola G; Sertoli MR; Gallino G; Piris A; Cattelan A; Lazzari I; Carrabba M; Scita G; Santantonio C; Pilla L; Tragni G; Lombardo C; Arienti F; Marchianò A; Queirolo P; Bertolini F; Cova A; Lamaj E; Ascani L; Camerini R; Corsi M; Cascinelli N; Lewis JJ; Srivastava P; Parmiani G
J Clin Oncol; 2002 Oct; 20(20):4169-80. PubMed ID: 12377960
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
